Key facts
- CoMind’s last known valuation is $34.2M (Apr 2021).
- It has raised $144.0M; the latest was Later Stage VC ($102.5M) in Aug 2025.
- Notable investors include Entrepreneurs First, Octopus Ventures, Phoenix Court, Crane Venture Partners, Plural — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for CoMind
- ·The full record, as it builds
Funding rounds
No funding rounds for CoMind are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CoMind
Developer of a neuro-sensing technology designed to positively change how humans interact with machines. The company's platform allows communication with the brain and augments and connects artificial intelligence, whilst simultaneously improving the understanding of the human mind and neurological disorders, enabling clients to enhance the interaction between humans and computers easily.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2018
- Employees
- 76
- Website
- comind.io/
- Ownership
- Privately Held (backing)
CoMind doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CoMind shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CoMind in its N-PORT filings yet. We sweep new filings monthly.